Showing information for HMDB0001072 ('ubiquinone')

Metabolite information
HMDB ID HMDB0001072
Synonyms
(all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione
(all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone
2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-P-benzoquinone
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-P-benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
4-Ethyl-5-fluoropyrimidine
Adelir
Aqua Q 10l10
Aqua Q10
CO-Enzyme Q10
CoQ
CoQ 10
CoQ10
Coenzyme Q10, (Z,Z,Z,Z,Z,Z,e,e,e)-isomer
Coenzyme Q10, ion (1-), (all-e)-isomer
Ensorb
Kaneka Q10
Kudesan
Li-Q-sorb
Liquid-Q
Neuquinon
Neuquinone
PureSorb Q 40
Q
Q 10AA
Q 199
Q-Gel
Q-Gel 100
Q-Ter
Q10
UBIQUINONE-10
Ubidecarenone
Ubiquinone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
Ubisemiquinone
Ubisemiquinone radical
Unbiquinone
Unispheres Q 10
all-trans-Ubiquinone
bio-Quinon
bio-Quinone Q10
Chemical formula C59H90O4
IUPAC name
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
CAS registry number 303-98-0
Monoisotopic molecular weight 862.683911368

Chemical taxonomy
Super class Lipids and lipid-like molecules
Class Prenol lipids
Sub class Quinone and hydroquinone lipids

Biological properties
Pathways (Pathway Details in HMDB)

The paper(s) that report HMDB0001072 as a lung cancer biomarker

The studies that identify HMDB0001072 as a lung cancer-related metabolite

Reference Country Specimen Marker function Participants (Case) Participants (Control)
Cancer type Stage Number Gender (M,F) Age mean (range) (M/F) Smoking status Type Number Gender (M,F) Age mean (range) (M/F) Smoking status
Wen et al. 2013 China plasma diagnosis adenocarcinoma I 31 15, 16 median: 63 (40-81) smoker, non-smoker healthy 28 20, 8 median: 37 (29-50) smoker, non-smoker
Chen et al. 2015b China serum – lung cancer (postoperative) – 30 – 61.58 ± 10.67 – healthy 30 – 60.35 ± 12.48 –
Reference Chromatography Ion source Positive/Negative mode Mass analyzer Identification level
Wen et al. 2013 LC ESI – Q-TOF MS/MS
Chen et al. 2015b LC ESI positive Q-TOF –
Reference Data processing software Database search
Wen et al. 2013 MassHunter, Mass Profiler Professional software (Agilent) NIST 08, HMDB, METLIN, LIPID MAPS
Chen et al. 2015b Mass Hunter Qualitative Analysis Software (Agilent Technologies) METLIN
Reference Difference method Mean concentration (case) Mean concentration (control) Fold change (case/control) P-value FDR VIP
Wen et al. 2013 Mann–Whitney–Wilcoxon test, OPLS-DA – – 5.62 1.15e-09 – 1.29
Chen et al. 2015b PCA, PLS-DA, independent t test – – 0.43 1.00e-03 – 1.29
Reference Classification method Cutoff value AUROC 95%CI Sensitivity (%) Specificity (%) Accuracy (%)
Wen et al. 2013 ROC curve analysis – 0.96 – – –
Chen et al. 2015b – – – – – –